BioAtla (BCAB) Assets (2020 - 2026)

BioAtla (BCAB) has reported Assets for 7 consecutive years, with $9.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 64.96% year-over-year to $9.5 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (down 64.96% YoY), and the FY2025 full-year result was $13.8 million, down 73.62% from the prior year.
• Assets climbed to $9.5 million in Q2 2026 per BCAB's latest filing, from $8.6 million in the prior quarter.
• Across five years, Assets topped out at $230.7 million in Q1 2022 and bottomed at $8.6 million in Q1 2026.
• Historically, Assets has averaged $105.6 million across 5 years, with a median of $78.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Assets grew 0.68% in 2022, then sank 77.63% in 2026.
• Over 5 years, Assets stood at $225.7 million in 2022, then tumbled by 46.99% to $119.7 million in 2023, then plunged by 56.19% to $52.4 million in 2024, then plunged by 73.62% to $13.8 million in 2025, then plunged by 31.26% to $9.5 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $9.5 million, $8.6 million, and $13.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.